Follow
Michael Harvie
Michael Harvie
University of Sri Jayewardenapura
No verified email
Title
Cited by
Cited by
Year
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ...
EBioMedicine 87, 2023
652023
Antibody and T cell responses to Sinopharm/BBIBP-CorV in naïve and previously infected individuals in Sri Lanka
C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ...
MedRxiv, 2021.07. 15.21260621, 2021
302021
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ...
Immunity, inflammation and disease 10 (6), e621, 2022
252022
Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals
C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ...
MedRxiv, 2021.10. 14.21265030, 2021
252021
Comparison of the immunogenicity of five COVID‐19 vaccines in Sri Lanka
C Jeewandara, IS Aberathna, S Danasekara, L Gomes, S Fernando, ...
Immunology 167 (2), 263-274, 2022
152022
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
B Raman, C McCracken, MP Cassar, AJ Moss, L Finnigan, AHA Samat, ...
The Lancet Respiratory Medicine 11 (11), 1003-1019, 2023
122023
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study
C Jackson, ID Stewart, T Plekhanova, PS Cunningham, AL Hazel, ...
The Lancet Respiratory Medicine 11 (8), 673-684, 2023
122023
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
B Zheng, G Vivaldi, L Daines, OC Leavy, M Richardson, O Elneima, ...
The Lancet Regional Health–Europe 29, 2023
122023
Seroprevalence of SARS-CoV-2 infection in the Colombo municipality region, Sri Lanka
C Jeewandara, D Guruge, IS Abyrathna, S Danasekara, B Gunasekera, ...
Frontiers in public health 9, 724398, 2021
122021
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
C Jeewandara, IS Aberathna, L Gomes, PD Pushpakumara, ...
Immunity, Inflammation and Disease 10 (4), e592, 2022
92022
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
C Jeewandara, S Fernando, PD Pushpakumara, ST Ramu, ...
Scientific Reports 12 (1), 1727, 2022
92022
Immune responses to Sinopharm/BBIBP‐CorV in individuals in Sri Lanka
C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ...
Immunology 167 (2), 275-285, 2022
82022
Surveillance of SARS-CoV-2 variants of concern by identification of single nucleotide polymorphisms in the spike protein by a multiplex real-time PCR
L Gomes, C Jeewandara, TP Jayadas, O Dissanayake, M Harvie, ...
Journal of virological methods 300, 114374, 2022
82022
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study
HJC McAuley, RA Evans, CE Bolton, CE Brightling, JD Chalmers, ...
EClinicalMedicine 57, 2023
72023
Immune responses to a single dose of the AZD1222/Covishield vaccine at 16 weeks in individuals in Sri Lanka
C Jeewandara, D Guruge, PD Pushpakumara, A Kamaladasa, ...
The Journal of Immunology 207 (11), 2681-2687, 2021
42021
Antibody and T cell responses to Sinopharm/BBIBP-CorV in naïve and previously infected individuals in Sri Lanka (preprint)
C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ...
22021
The burden of dengue in children and risk factors of transmission in nine districts in Sri Lanka
C Jeewandara, MV Karunananda, S Fernando, S Danasekara, ...
Journal of Medical Virology 96 (1), e29394, 2024
12024
Long COVID research: an update from the PHOSP-COVID Scientific Summit
CE Brightling, RA Evans, A Singapuri, N Smith, LV Wain, CE Brightling, ...
The Lancet Respiratory Medicine 11 (11), e93-e94, 2023
12023
Memory B cell responses at 16 weeks following a single dose of AZD1222/Covishield in Sri Lankan individuals
ST Ramu, C Jeewandara, H Kuruppu, P Pushpakumara, M Harvie, ...
International Journal of Infectious Diseases 116, S63, 2022
12022
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
G Malavige, C Jeewandara, H Fernando, PD Pushpakumara, ...
12021
The system can't perform the operation now. Try again later.
Articles 1–20